Tag: coronavirus vaccine


Jamie Dimon says economic boom fueled by deficit spending, vaccines could ‘easily run into 2023’

April 7, 2021


Jamie Dimon is bullish on the U.S. economy – at least for the next few years. In his annual shareholder letter, the long-time JPMorgan Chase chairman and CEO said he sees strong growth for the world’s biggest economy, thanks to […]

Finance Tech, Trading

S&P 500 climbs to record high as vaccine hopes lift economy-linked stocks

December 1, 2020

Via: Markets Insider

US stocks gained on Tuesday, a day after the Dow Jones industrial average completed its best month since 1987. The S&P 500 opened at a record high as vaccine progress continued to lift stocks battered the most by the coronavirus […]

Finance Tech, Trading

Global stocks rise for 2nd day on coronavirus vaccine hopes

November 10, 2020

Via: ABC News

Global stocks and U.S. futures rose for second day Tuesday on hopes for progress toward a possible coronavirus vaccine that might allow the world to revive manufacturing, shopping and normal life. Market benchmarks in London, Frankfurt and Tokyo advanced while […]

Finance Tech, Trading

Traders worry vaccine complacency is the new risk to the market

October 22, 2020


Is a vaccine the real risk to the market? Stocks are within 1% to 2% of their historic highs because of the belief that stimulus of some form is coming, the election will not devolve into chaos, and an effective […]

Finance Tech, Trading

U.S. stocks edge lower as earnings season kicks off, J&J pauses coronavirus vaccine trial

October 13, 2020

Via: Market Watch

U.S. stocks traded slightly lower early Tuesday as investors parsed earnings from some of the biggest financial institutions, to start the third-quarter reporting season. Wall Street participants also were watching a number of corporate events, including the start of Amazon’s […]

Finance Tech, Liquidity

Short the dollar if Biden wins the White House, Goldman Sachs suggests

October 12, 2020

Via: Fortune

The dollar may tumble to its lows of 2018 on the rising likelihood of Joe Biden winning the U.S. election and progress on a coronavirus vaccine, according to Goldman Sachs Group Inc. “The risks are skewed toward dollar weakness, and […]

Industries, Others

Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing

August 24, 2020

Via: Fortune

In a business driven by profit, vaccines have a problem. They’re not very profitable—at least not without government subsidies. Pharma companies favor expensive medicines that must be taken repeatedly and generate revenue for years or decades. Vaccines are often given […]


U.S. government secures 100 million doses of Pfizer, BioNTech vaccine for $2 billion

July 22, 2020

Via: Fortune

U.S. health officials agreed pay $1.95 billion for 100 million doses of a vaccine made by Pfizer Inc. and BioNTech SE, the latest step in an effort to fight the coronavirus pandemic. The companies will receive payment upon the receipt […]